INDENTURE Dated as of September 28, 2016 among IMS Health Incorporated, as Issuer, the Guarantors party hereto, US Bank National Association, as Trustee 5.000% SENIOR NOTES DUE 2026 3.500% SENIOR NOTES DUE 2024Indenture • October 3rd, 2016 • Quintiles IMS Holdings, Inc. • Services-commercial physical & biological research • New York
Contract Type FiledOctober 3rd, 2016 Company Industry JurisdictionINDENTURE, dated as of September 28, 2016, among IMS Health Incorporated, a Delaware corporation, each Guarantor (as defined herein) and U.S. Bank National Association, as Trustee.
QUINTILES IMS HOLDINGS, INC. AWARD AGREEMENT (Awarding Restricted Stock Units)Award Agreement • October 3rd, 2016 • Quintiles IMS Holdings, Inc. • Services-commercial physical & biological research • North Carolina
Contract Type FiledOctober 3rd, 2016 Company Industry JurisdictionTHIS AWARD AGREEMENT (this “Agreement”) is made by and between Quintiles IMS Holdings, Inc., a Delaware corporation (the “Company”), and «Name» (the “Participant”) pursuant to the provisions of the Quintiles IMS Holdings, Inc. 2013 Stock Incentive Plan (the “Plan”), which is incorporated herein by reference. Capitalized terms not defined in this Agreement shall have the meanings given to them in the Plan.
INDEMNIFICATION AGREEMENTIndemnification Agreement • October 3rd, 2016 • Quintiles IMS Holdings, Inc. • Services-commercial physical & biological research
Contract Type FiledOctober 3rd, 2016 Company IndustryThis Indemnification Agreement (“Agreement”) is made and entered into as of [ ], by and among Quintiles IMS Holdings, Inc., a Delaware corporation (the “Company”), Quintiles IMS Health Incorporated, a Delaware corporation (“Opco”, and together with the Company, the “Quintiles IMS Companies” and each a “Quintiles IMS Company”), and [__] (“Indemnitee”).
AMENDMENT NO. 3 TO THIRD AMENDED AND RESTATED CREDIT AGREEMENTCredit Agreement • October 3rd, 2016 • Quintiles IMS Holdings, Inc. • Services-commercial physical & biological research • New York
Contract Type FiledOctober 3rd, 2016 Company Industry JurisdictionSECOND LIEN INTERCREDITOR AGREEMENT dated as of [ ], 20[ ] (as amended, supplemented or otherwise modified from time to time, this “Agreement”), among HEALTHCARE TECHNOLOGY INTERMEDIATE, INC., a Delaware corporation (“Holdings”), IMS HEALTH INCORPORATED, a Delaware corporation (the “Parent Borrower”), the other Grantors (as defined below) from time to time party hereto, BANK OF AMERICA, N.A., as Representative for the Credit Agreement Secured Parties (in such capacity, the “Administrative Agent”), [INSERT NAME AND CAPACITY], as Representative for the Initial Second Priority Debt Parties (in such capacity and together with its successors in such capacity, the “Initial Second Priority Representative”), [[ ], as Representative for the Additional Senior Debt Parties under the [describe applicable Additional Senior Debt Facility]]and each additional Second Priority Representative and Senior Representative that from time to time becomes a party hereto pursuant to Section 8.09.1